Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antivirals against the Chikungunya Virus
Verena Battisti, Ernst Urban, Thierry Langer
Viruses (2021) Vol. 13, Iss. 7, pp. 1307-1307
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development
Thaíse Yasmine Vasconcelos de Lima Cavalcanti, Mylena Ribeiro Pereira, Sérgio Oliveira de Paula, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 969-969
Open Access | Times Cited: 152
Chikungunya fever
Koen Bartholomeeusen, Matthieu Daniel, Desiree A. LaBeaud, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 110
Chikungunya: An Emerging Public Health Concern
Omar Mourad, Leila Makhani, Lin H. Chen
Current Infectious Disease Reports (2022) Vol. 24, Iss. 12, pp. 217-228
Open Access | Times Cited: 46
In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses
Shirin Mahmoodi, Javad Zamani Amirzakaria, Abdolmajid Ghasemian
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285177-e0285177
Open Access | Times Cited: 30
Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review
Mengke Wang, Lidong Wang, Ping Leng, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129949-129949
Closed Access | Times Cited: 12
Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4′-Fluorouridine
Peiqi Yin, Elizabeth B. Sobolik, Nicholas May, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012859-e1012859
Open Access | Times Cited: 1
The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses
Anthony K. L. Leung, Diane E. Griffin, Jürgen Bosch, et al.
Pathogens (2022) Vol. 11, Iss. 1, pp. 94-94
Open Access | Times Cited: 32
The research progress of Chikungunya fever
Li Cai, Xinyi Hu, Shuang Liu, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 17
Pathogenicity and virulence of chikungunya virus
Wesley Freppel, Laurie A. Silva, Kenneth A. Stapleford, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin
Xin-Yang Liu, Wei Xie, He‐Yang Zhou, et al.
Journal of Integrative Medicine (2024)
Closed Access | Times Cited: 6
Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study
Kusuma Sai Davuluri, Rajnandini Ghanghav, Gunwant Ahire, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Synthesis and antiviral activities of quinazolinamine–coumarin conjugates toward chikungunya and hepatitis C viruses
Jih Ru Hwu, Mohit Kapoor, Nitesh K. Gupta, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114164-114164
Open Access | Times Cited: 20
4′-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo
Peiqi Yin, Nicholas May, Laura Sandra Lello, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 4
Chikungunya: The Silent Threat in the Shadows
Ambreen Talib, Rabbya Rayan Shah, Rameen Atique, et al.
Clinical Microbiology Newsletter (2025)
Closed Access
Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures
Alyssa M. Lantz, Victoria K. Baxter
Viruses (2025) Vol. 17, Iss. 2, pp. 261-261
Open Access
Revolutionizing Chikungunya Vaccines: mRNA Breakthroughs With Molecular and Immune Simulations
Md. Habib Ullah Masum, Ahmad Abdullah Mahdeen, Abanti Barua
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications
Raquel de Oliveira Souza, José Wandilson Barboza Duarte Júnior, Victória Simões Della Casa, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Evolution and immunopathology of chikungunya virus informs therapeutic development
Filipa Henderson Sousa, Amalina Ghaisani Komarudin, Fern Findlay-Greene, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 4
Open Access | Times Cited: 7
The Dimeric Peptide (KKYRYHLKPF)2K Shows Broad-Spectrum Antiviral Activity by Inhibiting Different Steps of Chikungunya and Zika Virus Infection
Gabriela Miranda Ayusso, Maria Letícia Duarte Lima, Paulo R. S. Sanches, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1168-1168
Open Access | Times Cited: 7
In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell‐based approaches
Meenakshi Chaudhary, Akash Kumar, Kiran Bala Sharma, et al.
FEBS Journal (2024) Vol. 291, Iss. 12, pp. 2656-2673
Closed Access | Times Cited: 2
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening
Jasmin C. Aschenbrenner, André S. Godoy, M. Fairhead, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics
Madison T. Gray, Israel Guerrero‐Arguero, Antonio Solis‐Leal, et al.
PeerJ (2022) Vol. 10, pp. e13090-e13090
Open Access | Times Cited: 10
The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus
Ana C. Puhl, R.S. Fernandes, André S. Godoy, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 83, pp. 117239-117239
Open Access | Times Cited: 6
The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication
Lucca Rocha Policastro, Isabela Dolci, André S. Godoy, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1351-1351
Open Access | Times Cited: 9
MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro , In Vivo , and Ex Vivo
Saikat De, Soumyajit Ghosh, Supriya Suman Keshry, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 7
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top